Yan-Ping Xu1, Jian-Miao Hu2, Ye-Qing Huang3, Li-Ping Shi3. 1. NICU, The Children's Hospital, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, China. xuyanping726@zju.edu.cn. 2. Yiwu Branch of Children's Hospital, Zhejiang University School of Medicine, Yiwu, China. 3. NICU, The Children's Hospital, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, China.
Abstract
PURPOSE: Perinatal Ureaplasma infection is associated with a variety of adverse outcomes and neonatal diseases. This meta-analysis is to evaluate current evidence evaluating the association between Ureaplasma and adverse pregnancy outcomes and bronchopulmonary dysplasia (BPD) in preterm infants. METHODS: We searched for published articles on Ureaplasma, preterm and BPD in PubMed, the Cochrane Library, and Embase databases posted before August 28, 2021. In addition, the references of these articles were screened. A random/fixed-effect model was used to synthesize predefined outcomes. RESULTS: A total of 19 cohort studies involving 11,990 pregnancy women met our inclusion criteria. Pregnancy Ureaplasma positive increased the risk of preterm birth [odds ratios (OR) 2.76, 95% confidence intervals (CI) 1.63-4.68], BPD (OR 2.39 95% CI 1.73-3.30), chorioamnionitis (OR 2.71, 95% CI 2.02-3.64) and premature rupture of membranes (PROM, OR 2.19, 95% CI 1.34-3.58). CONCLUSIONS: Pregnancy Ureaplasma positive may increase the risk of developing preterm birth, chorioamnionitis, PROM and BPD in the preterm infant. The evidence base is, however, of low quality and well-designed studies are needed.
PURPOSE: Perinatal Ureaplasma infection is associated with a variety of adverse outcomes and neonatal diseases. This meta-analysis is to evaluate current evidence evaluating the association between Ureaplasma and adverse pregnancy outcomes and bronchopulmonary dysplasia (BPD) in preterm infants. METHODS: We searched for published articles on Ureaplasma, preterm and BPD in PubMed, the Cochrane Library, and Embase databases posted before August 28, 2021. In addition, the references of these articles were screened. A random/fixed-effect model was used to synthesize predefined outcomes. RESULTS: A total of 19 cohort studies involving 11,990 pregnancy women met our inclusion criteria. Pregnancy Ureaplasma positive increased the risk of preterm birth [odds ratios (OR) 2.76, 95% confidence intervals (CI) 1.63-4.68], BPD (OR 2.39 95% CI 1.73-3.30), chorioamnionitis (OR 2.71, 95% CI 2.02-3.64) and premature rupture of membranes (PROM, OR 2.19, 95% CI 1.34-3.58). CONCLUSIONS: Pregnancy Ureaplasma positive may increase the risk of developing preterm birth, chorioamnionitis, PROM and BPD in the preterm infant. The evidence base is, however, of low quality and well-designed studies are needed.
Authors: David C Kasper; Thomas P Mechtler; Judith Böhm; Ljubomir Petricevic; Andreas Gleiss; Joachim Spergser; Armin Witt; Kurt R Herkner; Angelika Berger Journal: J Perinat Med Date: 2011-05 Impact factor: 1.901
Authors: Kenichiro Motomura; Roberto Romero; Yi Xu; Kevin R Theis; Jose Galaz; Andrew D Winters; Rebecca Slutsky; Valeria Garcia-Flores; Chengrui Zou; Dustyn Levenson; Robert Para; Madison M Ahmad; Derek Miller; Chaur-Dong Hsu; Nardhy Gomez-Lopez Journal: mBio Date: 2020-06-23 Impact factor: 7.867
Authors: Rose Marie Viscardi; Michael L Terrin; Laurence S Magder; Natalie L Davis; Susan J Dulkerian; Ken B Waites; Namasivayam Ambalavanan; David A Kaufman; Pamela Donohue; Deborah J Tuttle; Jorn-Hendrik Weitkamp; Hazem E Hassan; Natalie D Eddington Journal: Arch Dis Child Fetal Neonatal Ed Date: 2020-03-13 Impact factor: 5.747